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Preventing tissue-factor-(TF-) mediated systemic coagulopathy improves outcome in models of sepsis. Preventing TF-mediated
pulmonary coagulopathy could attenuate ventilator-induced lung injury (VILI). We investigated the eﬀect of relative TF deﬁciency
on pulmonary coagulopathy and inﬂammation in a murine model of VILI. Heterozygous TF knockout (TF
+/−) mice and their
wild-type (TF
+/+) littermates were sedated (controls) or sedated, tracheotomized, and mechanically ventilated with either low
or high tidal volumes for 5 hours. Mechanical ventilation resulted in pulmonary coagulopathy and inﬂammation, with more
injury after mechanical ventilation with higher tidal volumes. Compared with TF
+/+ mice, TF
+/− mice demonstrated signiﬁcantly
lower pulmonary thrombin-antithrombin complex levels in both ventilation groups. There were, however, no diﬀerences in lung
wet-to-dry ratio, BALF total protein levels, neutrophil inﬂux, and lung histopathology scores between TF
+/− and TF
+/+ mice.
Notably, pulmonary levels of cytokines were signiﬁcantly higher in TF
+/− as compared to TF
+/+ mice. Systemic levels of cytokines
were not altered by the relative absence of TF. TF deﬁciency is associated with decreased pulmonary coagulation independent of
the ventilation strategy. However, relative TF deﬁciency does not reduce VILI and actually results in higher pulmonary levels of
inﬂammatory mediators.
1.Introduction
Mechanical ventilation (MV) is an indispensable tool in
the treatment of patients with acute respiratory failure and
is mandatory during general anesthesia. However, MV can
aggravate preexisting lung injury or even induce lung injury
in healthy lungs [1–3]. This phenomenon is frequently
referred to as ventilator-induced lung injury (VILI) in ani-
mals or ventilator-associated lung injury (VALI) in humans
[4]. All mechanically ventilated patients may be at risk for
VALI.
Pulmonary coagulopathy is a characteristic feature of
acute lung injury [5] and pneumonia [5, 6] and is the result
of localized tissue-factor-(TF-) mediated thrombin genera-
tion, impaired activity of natural inhibitors of coagulation
[7, 8], and depressed bronchoalveolar urokinase plasmino-
gen activator-mediated ﬁbrinolysis, caused by an increase
of plasminogen activator inhibitors [9]. Pulmonary ﬁbrin2 Critical Care Research and Practice
turnover is also inﬂuenced by MV [10, 11]. Indeed, in a
rat model of thrombin and ﬁbrinogen instillation, induced
pulmonary coagulopathy MV with high tidal volumes (VT)
attenuated ﬁbrinolytic activity via an increase of local
plasminogen activator inhibitors [10]. Similar results were
obtained in a model of endotoxin-induced lung injury [11].
In humans, MV during general anesthesia with settings that
have been shown to be harmful causes activation of bron-
choalveolar coagulation, as reﬂected in a marked increase in
thrombin-antithrombin complexes (TATc), soluble TF, and
factor VIIa [12]. Lung-protective ventilator settings largely
attenuate these changes in procoagulant activity within the
airways.
The direct relation between local TF expression and VILI
has never been elucidated. Therefore, the main objective
of this study was to determine the role of endogenous TF
in alveolar coagulopathy and pulmonary inﬂammation in
response to MV. We hypothesize animals with diﬀerences in
TF expression to respond in a diﬀerent way to VILI. For this,
we ventilated heterozygous TF knockout (TF+/−) mice and
theirwild-type(TF+/+)littermateswitheitherlowVT orhigh
VT.
2.MaterialsandMethods
The study was approved by the Animal Care and Use
Committee of the Academic Medical Center of the Univer-
sity of Amsterdam, Amsterdam, The Netherlands. Animal
procedures were carried out in compliance with Institutional
Standards for Human Care and Use of Laboratory Animals.
2.1. Mice. Experiments were performed with heterozygous
TF knockout mice (TF+/−, N = 36) and their wild-type
littermates (TF+/+, N = 36), aged 13–17 weeks. Disruption
o ft h em o u s et i s s u ef a c t o rg e n e( T F −/−)l e a d st oe m b r y -
onic lethality [13], while heterozygotes appear normal and
free of bleeding complications. TF+/− mouse embryonic
ﬁbroblasts have only slightly prolonged clotting times in
vitro. Schoenmakers have shown that clotting times are very
similar in TF+/− mice compared with TF+/+ mice, after
stimulating with endotoxin [13]. This suggest that TF is
dominantly expressed and that lack of the gene in one allele
does not aﬀect the coagulation phenotype. TF+/− mice, on
a C57Bl/6 background [14], were bred and maintained at
the animal care facility of the Academic Medical Center.
Sedated but nonventilated mice served as controls (N = 12
for either TF+/− or TF+/+ mice). Sedated and tracheotomized
mice were ventilated with 2 diﬀerent ventilation strategies
(see below). In total this resulted in 6 groups of animals (see
below).
2.2. Instrumentation and Anesthesia. Throughout the exper-
iments rectal temperature was monitored and maintained
between 36.0 and 37.5◦C using a warming pad. Anesthesia
was achieved with intraperitoneal injection of a mix of
ketamine (Eurovet Animal Health BV, Bladel, The Nether-
lands), medetomidine (Pﬁzer Animal Health BV, Capelle
a/d IJssel, The Netherlands), and atropine (Pharmachemie,
Haarlem, The Netherlands) (KMA) as described previously
[15, 16]. Induction anesthesia consisted of injection of
KMA “induction” mix: 7.5μLp e rg r a mo fb o d yw e i g h t
of 1.26mL 100mg/mL ketamine, 0.2mL 1mg/mL medeto-
midine, and 1mL 0.5mg/mL atropine in 5mL normal
saline.Maintenanceanesthesiaconsistedofinjectionof10μL
per gram body weight of KMA “maintenance” mix, con-
sisting of 0.72mL 100mg/mL ketamine, 0.08mL 1mg/mL
medetomidine, and 0.3mL 0.5mg/mL atropine, in 20mL
normal saline. Maintenance mix was administered via an
intraperitoneal catheter (PE 10 tubing, BD, Breda, The
Netherlands) every hour.
2.3. Mechanical Ventilation Strategies. An Y-tube connector,
1.0mm outer diameter and 0.6mm inner diameter (VBM
Medizintechnik GmbH, Sulz am Neckar, Germany), was
surgically inserted into the trachea under general anesthesia.
Mice were placed in a supine position and connected to a
humanventilator(Servo900C,Siemens,Sweden).Micewere
pressure-controlled ventilated with either an inspiratory
pressure of 10cmH2O (resulting in VT of about 7.5mL/kg;
lower VT,L VT) or an inspiratory pressure of 18cmH2O
(resulting in VT of about 15mL/kg; higher VT,H VT)
as described before [15, 16]. Respiratory rate was set at
110 breaths/min and 50 breaths/min with LVT and HVT,
respectively. These respiratory settings resulted in normal
PaCO2 values after 5h of mechanical ventilation [15]. PEEP
was set at 2cmH2O with both ventilation strategies. The
fraction of inspired oxygen was kept at 0.5. The inspiration
to expiration ratio was kept at 1:1 throughout the exper-
iment. A sigh (sustained inﬂation with 30cm H2O) for 5
breaths was performed every 30 minutes. Mice received an
intraperitoneal bolus of 1mL normal saline 1 hour before
start of anesthesia and initiation of MV, followed by 0.2mL
sodium bicarbonate (200mmol/LNaHCO3) administered
via the intraperitoneal catheter every 30 minutes until the
e n do fM V .
2.4. Hemodynamic and Ventilatory Monitoring. Systolic
blood pressure and heart rate were noninvasively monitored
using a murine tail-cuﬀ system (ADInstruments, Spechbach,
Germany). VT was checked hourly with a specially designed
mice “Fleisch-tube” connected to the warmed plethysmo-
g r a p hs y s t e m .T h eﬂ o ws i g n a lw a si n t e g r a t e df r o mad i ﬀer-
ential pressure transducer, and data were recorded and dig-
itized online using a 16-channel data-acquisition program
(ATCODAS, Dataq Instruments Inc, ‘s-Hertogenbosch, The
Netherlands) and stored on a computer for postacquisition
oﬀ line analysis. A minimum of 5 consecutive breaths was
selected for analysis of the digitized VT signals.
2.5. Study Groups. Nonventilated control mice (TF+/− and
TF+/+ mice; N = 12) received half the dose of anesthesia,
were spontaneously breathing, and sacriﬁced after 5 hours.
LVT mice and HVT mice (TF+/− and TF+/+ mice) were
mechanically ventilated for 5 hours and then sacriﬁced. Half
of these mice (N = 6) were sacriﬁced, and blood was
drawn from the inferior vena cava into a sterile syringe,
transferred to EDTA-coated tubes, and immediately placedCritical Care Research and Practice 3
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Figure 1: Hemodynamic parameters during 5 hours of mechanical ventilation. Systolic blood pressure (a) and heart rate ((b); beats/min)
were measured at three time points (t = 0, 2.5, and 5 hours after start of mechanical ventilation) in mice ventilated with low tidal volumes
(LVT) and high tidal volumes (HVT). Each mentioned group consisted of heterozygote TF knockout (TF+/−) mice and their wild-type
littermates (TF+/+). Data represent means of 12 mice.
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Figure 2: Bronchoalveolar lavage ﬂuid thrombin-antithrombin complex (TATc) and plasminogen activator inhibitor (PAI)-1 levels in con-
trol mice (C) and mice ventilated for 5 hours with lower tidal volumes (LVT) or higher VT (HVT). Each group consisted of heterozygote TF
knockout mice (TF+/−) and their wild-type littermates (TF+/+). Data represent medians and interquartile range of six mice. ∗P<0.05 versus
TF+/+ mice.
on ice. Subsequently, bronchoalveolar lavage ﬂuid (BALF)
was obtained from the right lung; the left lung was used
to measure wet/dry ratios. In the other half of these mice
(N = 6),bloodwassampledfromthecarotidarteryandused
for blood gas analysis. The lungs of these mice were used for
homogenate (right lung) and histopathology (left lung).
2.6. Blood Gas Analysis. For blood gas analysis, blood was
immediately analyzed in a Rapidlab 865 blood gas analyzer
(Bayer, Mijdrecht, The Netherlands). The other blood sam-
ples were centrifuged at 3000rpm at 4◦Cf o r1 0 m i na n d
the supernatants were aliquoted and frozen at −20◦C until
assayed.4 Critical Care Research and Practice
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Figure 3: Wet-to-dry ratios, number of neutrophil cells, and total protein level in bronchoalveolar lavage ﬂuid after 5 hours in control mice
(C) and mice ventilated for 5 hours with lower tidal volumes (LVT) or higher VT (HVT). Each group consisted of heterozygote TF knockout
mice (TF+/−) and their wild-type littermates (TF+/+). Data represent medians and interquartile range of six mice. Diﬀerences between TF+/−
and TF+/+ are not statistically signiﬁcant.
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Figure 4: Histopathology scores in control mice (C) and mice
ventilated for 5 hours with lower tidal volumes (LVT) or higher
VT (HVT). Each group consisted of heterozygote TF knockout
mice(TF+/−)andtheirwild-typelittermates(TF+/+).Datarepresent
means and SEM of six mice. Diﬀerences between TF+/− and TF+/+
are not statistically signiﬁcant.
2.7. Lung Wet-to-Dry Ratios. For lung wet-to-dry ratios, the
left lung was weighed and subsequently dried for three days
in an oven at 65◦C. The ratio of wet weight to dry weight
represents tissue edema.
2.8. Lung Homogenates. During sacriﬁcing the right lung
was removed and snap frozen in liquid nitrogen. These
frozen specimens were suspended in 4 volumes of sterile
isotonic saline, subsequently lysed in 1 volume of lysis buﬀer
(150mMNaCl, 15mM Tris (tris(hydroxymethyl)amino-
methane),1mMMgCl·H2O, 1 mM CaCl2,1%TritonX-100,
100μg/mL pepstatin A, leupeptin and aprotinin, pH 7.4),
and incubated at 4◦C for 30min. Homogenates were spun at
3400rpm at 4◦C for 15 minutes after which the supernatants
were stored at −20◦C until assayed.
2.9. Bronchoalveolar Lavage. BALF was obtained by instill-
ing three times 0.5mL aliquots of saline into the right
lung by a 22-gauge Abbocath-T catheter (Abbott, Sligo,
Ireland). Approximately, 1.0mL of lavage ﬂuid was retrieved
per mouse, and cell counts were determined using a
hemacytometer (Beckman Coulter, Fullerton, CA, USA).
Subsequently, diﬀerential counts were done on cytospin
preparations stained with a modiﬁed Giemsa stain, Diﬀ-
Quick (Dade Behring AG, D¨ udingen, Switzerland). Super-
natant was stored at −80◦C for total protein level, thrombin-
antithrombincomplexes,andlevelsofplasminogenactivator
inhibitor (PAI)-1.
2.10. Histopathology. For histopathology lungs were ﬁxed
in 4% formalin and embedded in paraﬃn. 4μms e c t i o n s
were stained with hematoxylin-eosin (H&E), and analyzed
by a pathologist who was blinded for group identity. To
score lung injury, we used a modiﬁed VILI histology scoring
systemaspreviouslydescribed[17].Inshort,fourpathologic
parameters were scored on a scale of 0–4: (a) alveolar
congestion, (b) hemorrhage, (c) leukocyte inﬁltration, and
(d) thickness of alveolar wall/hyaline membranes. A score of
0representsnormallungs;(1)mild,<25%lunginvolvement;Critical Care Research and Practice 5
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Figure 5: Histological specimens from lungs of control mice (a and d) and mice ventilated with lower tidal volumes (LVT; b and e) or higher
VT (HVT; c and f) for 5 hours. Upper panel, represent wild-type mice (TF+/+) and lower panel, represent heterozygote TF knock-out mice
(TF+/−). Hematoxylin-eosin stain; magniﬁcation 200×.
(2) moderate, 25–50% lung involvement; (3) severe, 50–75%
lung involvement; (4) very severe, >75% lung involvement.
The total histology score was expressed as the sum of the
score for all parameters.
2.11. Assays. Total protein levels in BALF were determined
using a Bradford Protein Assay Kit (OZ Biosciences, Mar-
seille, France) according to manufacturers’ instructions
with bovine serum albumin as standard. Cytokine and
chemokine levels in lung homogenates were measured by
enzyme-linked immunosorbent assay (ELISA) according
to the manufacturer’s instructions. Tumor necrosis factor
alpha (TNF), interleukin-(IL-) 6, macrophage inﬂammatory
protein (MIP)-2 and keratinocyte-derived chemokine (KC)
assays were all obtained from R&D Systems (Abingdon,
UK). Thrombin-antithrombin complex levels in BALF were
measured with a mouse speciﬁc ELISA as previously
described [18]. Levels of PAI-1 were measured by means
of a commercially available ELISA (Kordia, Leiden, The
Netherlands).
2.12. Statistical Analysis. All data in the results are expressed
as means ± SEM or median ± interquartile range, where
appropriate. To detect diﬀerences between groups, the
Dunnett method, in conjunction with two-way analysis of
variance, was used. A P-value of <0.05 was considered
signiﬁcantly. All statistical analyses were carried out using
SPSS 12.0.2 (SPSS, Chicago, IL, USA).
3. Results
3.1. Hemodynamic and Ventilatory Monitoring. All instru-
mented animals survived 5 hours of MV after which they
were sacriﬁced. Control animals survived anesthesia and
were also sacriﬁced after 5 hours. Hemodynamic monitoring
demonstrated stable conditions throughout the experiment
with no diﬀerences between TF+/− and TF+/+ mice and ven-
tilation groups (Figure 1). Blood gas analysis from LVT-mice
and HVT-mice are demonstrated in Table 1.N od i ﬀerences
were observed between groups, except from arterial oxygen
tension (PaO2), which was signiﬁcantly higher in HVT-mice
as compared to LVT-mice.
3.2. Ventilator-Induced Pulmonary Coagulopathy. BALF
TATc levels were higher in both ventilation groups as
compared to control mice (P = 0.006 for LVT-mice and
P<0.001 for HVT-mice), with higher levels in HVT-mice
(P<0.001 versus LVT-mice; Figure 2). Compared with
TF+/+ mice, TF+/− mice demonstrated lower BALF TATc
levels in both ventilation groups (P = 0.04 and P = 0.0026
in LVT-mice and HVT-mice, resp.).
B A L FP A I - 1l e v e l sw e r eh i gh e ri nb o t hv e n t i l a t i o ngr o u p s
as compared to control mice (P = 0.001 for LVT-mice and
P<0.001 for HVT-mice), with higher levels in HVT-mice
(P<0.007 versus LVT-mice; Figure 2). No diﬀerences were
observed between TF+/+ and TF+/− mice regarding BALF
PAI-1 levels.6 Critical Care Research and Practice
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Figure 6: Pulmonary levels tumor necrosis factor alpha (TNF), interleukin (IL)-6, macrophage inﬂammatory protein (MIP)-2, and
keratinocyte-derived chemokine (KC) in lung tissue homogenate in control mice (C) and mice ventilated for 5 hours with lower tidal
volumes (LVT) or higher VT (HVT). Each group consisted of heterozygote TF knock-out mice (TF+/−) and their wild-type littermates
(TF+/+). Data represent medians and interquartile range of six mice. ∗P<0.05 versus TF+/+ mice.
3.3. Lung Wet-to-Dry Ratio, Total Protein and Neutrophils
in BALF. Compared with LVT-mice and control mice, lung
wet-to-dry ratios were higher in HVT-mice (P = 0.039 and
P<0.001, resp.; Figure 3). In accordance, BALF total protein
levels were higher in HVT- m i c ea sc o m p a r e dt oL VT-mice
and control mice (P<0.001 and P<0.001, resp.; Figure 3).
Also the numbers of neutrophils in the BALF were higher
in HVT-mice as compared to control mice (P<0.001),
and there was a trend of higher numbers of neutrophils
in LVT-mice as compared to control mice (P = 0.059;
Figure 3). No diﬀerences were seen between TF+/− and TF+/+
mice with respect to lung wet-to-dry ratio, total protein and
neutrophils in BALF.
3.4. Lung Histopathology. Histopathological changes were
minor (Figures 4 and 5). None of the lungs showed signs
of inﬂammation, congestion or hyaline membranes. Only
hemorrhage could be seen. The pulmonary histopathology
score was higher in HVT-mice as compared to LVT-mice and
controlmice(P = 0.001andP<0.001,resp.).Nodiﬀerences
in histopathology were seen between TF+/− mice and TF+/+
mice.
3.5. Inﬂammatory Mediators. HVT-mice consistently dem-
onstrated higher pulmonary levels of TNF, IL-6, MIP-2 and
KC as compared to LVT-mice and control mice (for all
mediators P<0.001 and P<0.001, resp.; Figure 6). Com-
pared to TF+/+ mice, TF+/− mice had higher levels of IL-6 in
both ventilation groups (P = 0.002 for LVT mice and HVT
mice, resp.), and levels of TNF were higher in TF+/− mice as
compared to TF+/+ mice ventilated with HVT (P = 0.002).
Similarly, TF+/− mice demonstrated higher levels of MIP-2Critical Care Research and Practice 7
Table 1: Arterial blood gas analysis after 5 hours of mechanical ventilation.
LVT HVT
TF+/− TF+/+ TF+/− TF+/+
pH 7.44 ± 0.08 7.45 ± 0.06 7.44 ± 0.07 7.44 ± 0.08
PaCO2 (mmHg) 35 ± 10 34 ± 83 3 ± 83 3 ± 8
PaO2 (mmHg) 165 ± 39 172 ± 48 236 ± 24† 234 ± 26∗
HCO3
− (mmol/L) 22.7 ± 2.9 22.6 ± 2.3 22.5 ± 2.1 21.1 ± 1.9
BE −0.8 ± 2.7 −0.5 ± 0.7 0.8 ± 2.1 −2.1 ± 1.8
Data represent mean ± SD; LVT:m i c ev e n t i l a t e df o r5hw i t hVT of 7.5mL/kg; HVT:m i c ev e n t i l a t e df o r5hw i t hVT of 15mL/kg. TF+/−:h e t e r o z y g o u sT F
knockout mice; TF+/+: wild-type littermates; N = 6p e rg r o u p .∗P<0.05; †P<0.01 versus LVT ventilation.
(compared with ventilation with LVT, P = 0.002) and KC
(P = 0.002 and P = 0.015 compared with LVT-mice and
HVT-mice, resp.).
Systemic levels of TNF and MIP-2 were below detection
limits. Systemic levels of IL-6 and KC were elevated in both
ventilation groups as compared to control (P<0.001 and
P<0.001 for LVT mice and HVT mice, resp.). No diﬀerences
were seen between TF+/− and TF+/+ mice (Figure 7).
4. Discussion
ThereismountingevidenceindicatingthatTFplaysapivotal
role in the procoagulant response in the pulmonary com-
partment during various forms of pulmonary inﬂammation
and lung injury [19–21]. The present data show TF also
to be associated with pulmonary ventilator-induced coagu-
lopathy. Indeed, relative TF deﬁciency attenuated pulmonary
ventilator-induced activation of coagulation, while leaving
ventilator-induced inhibition of ﬁbrinolysis unchanged. Rel-
ative TF deﬁciency, however, did not attenuate VILI. In
fact, relative TF deﬁciency induced more inﬂammation, as
reﬂected by higher pulmonary levels of proinﬂammatory
cytokines and chemokines. Our study is among the ﬁrst
to investigate the potential role of TF in ventilator-induced
inﬂammation.
Because of extensive crosstalk between coagulation and
inﬂammation, causing reciprocal activation and ampliﬁca-
tion, one may expect relative TF deﬁciency-related atten-
uation of ventilator-induced pulmonary coagulopathy to
be associated with less pulmonary inﬂammation. This was
indeed found in a murine model of intestinal ischemia-
reperfusion-inducedlunginjury[22].InhumanTFknock-in
transgenic mice, He et al. demonstrated that administration
ofananti-humanTFmonoclonalantibody(mAb)attenuates
severity of lung tissue injury and decreases total cell counts
and protein concentrations in BALF. In addition, treatment
with anti-human TF mAb resulted in reduced alveolar ﬁbrin
deposition and decreased TF and PAI-1 activity in serum.
Pulmonary levels of inﬂammatory cytokines and cell death
were also reduced by treatment of anti-human TF mAb. In
a rat model of lung injury induced by LPS, blockade of
the TF-FVIIa complex protects the lung from injury in part
by reducing local expression of proinﬂammatory cytokines
[23].Thediﬀerencesfoundinthesestudiesandourscouldbe
explained,atleastinpart,bythefactthatgeneticbackground
caninﬂuencethediﬀerentresponsesofanimalstochallenges.
Several studies, however, show inhibition of the TF path-
way not to dampen inﬂammation. Indeed, in an Escherichia
coli peritonitis mice model, treatment with rNAPc2, a potent
and selective small protein inhibitor of the TF-pathway,
attenuated the local procoagulant response but did not
attenuate inﬂammation [24]. In addition, in a Streptococcus
pneumoniae pneumonia model in mice, while rNAPc2
treatment attenuated the procoagulant response, it increased
pulmonary levels of KC and MIP-2, without inﬂuencing
clearance of bacteria [25]. Our ﬁndings are in agreement
with these results, showing higher levels of inﬂammatory
mediatorsinthepulmonarycompartmentafterMVinTF+/−
mice as compared to TF+/+ mice.
Our results indicate that diﬀerences in TF expression are
associated with diﬀerences in ventilator-induced coagulopa-
thy. As expected, relative TF deﬁciency resulted in attenua-
tion of activation of coagulation, while leaving ﬁbrinolysis
unchanged. Inactivation of the TF pathway, thus, may lead
to less coagulation and less ﬁbrin deposition in the airways
during MV. On the other hand, less TF activity leads to more
pulmonary inﬂammation in our VILI model after 5 hours
of MV. It can be hypothesized that the cytokine levels in
TF+/+ mice peaked earlier and that the mice with a relative
TFdeﬁciencyshowaslowerpulmonarycytokineresponse.In
a recently published paper of Hegeman and colleagues, they
show that the cytokine peak in the lung is after two hours
of MV in healthy mice ventilated with a peak inspiratory
pressure of 20cmH2Oa n d0c mH 2O PEEP [26]. Adhesion
molecules, cytokines, and chemokines are all upregulated
in organs distal to the lung, such as liver and kidney due
to alveolar stretch imposed by MV in this last mentioned
study. Endothelial activation and inﬂammation in the lung
and distal organs are likely to play a role in the various
interrelated processes that lead to VILI and other MV-related
complications [27, 28], such as multiorgan dysfunction
syndrome and possibly ventilator-associated pneumonia.
VILIcanexacerbateexistinglunginjuryormakethelung
more sensitive to further injury (so-called two-hit model),
which is signiﬁcant with large transfusions, large ﬂuid shifts,
cardiopulmonary bypass, and lung ischaemia-reperfusion
injury.VILIinvolvesacomplicatedinteractionofoverdisten-
sion of alveoli, increased transpulmonary pressure, cycling
opening, and closing of alveoli and inﬂammatory mediators.
Mechanotransduction is the link between the physical forces
imposed on the lung and intracellular signaling pathways
leading totheproduction ofcytokines andotherbiomarkers.8 Critical Care Research and Practice
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Figure 7: Systemic levels of interleukin (IL)-6 and keratinocyte-derived chemokine (KC) in plasma after 5 hours in control mice (C) and
mice ventilated for 5 hours with lower tidal volumes (LVT) or higher VT (HVT). Each group consisted of heterozygote TF knock-out mice
(TF+/−) and their wild-type littermates (TF+/+). Data represent medians and interquartile range of six mice. Diﬀerences between TF+/− and
TF+/+ are not statistically signiﬁcant.
Shear stress induces proinﬂammatory cytokines, mostly
by upregulation of nuclear factor (NF)-κB in endothelial,
epithelial, and macrophage cells and induces a procoagulant
stateinthepulmonarycompartment.Itremainsthequestion
if pulmonary coagulopathy promoting ﬁbrin depositions
in the airways reﬂects an adaptive mechanism with host
protective function or whether it is a harmful process
predisposing the lungs to more complications.
One shortcoming of our study lies in the use of genet-
ically modiﬁed animals. The genetic background of trans-
genic mice can inﬂuence diﬀerent responses. Indeed, when
we knock out or knock down a gene fromthe genome, it may
trigger compensatory mechanisms. The responses of trans-
genic animals to a challenge, thus, reﬂect the dysfunction
(or alteration of the function) of the gene of interest plus
compensatory mechanisms. Therefore, the lack of diﬀerence
between TF+/− and TF+/+ mice cannot exclude the possibility
of using anti-TF therapies for VILI. Additional studies are
needed to test this hypothesis.
Our model has several limitations. First, MV with LVT
could promote development of atelectasis. In our model we
used deep inﬂation every 30 minutes to prevent atelectasis.
Periodicdeepinﬂationcanopenthelungbut,ifdeliveredtoo
frequently, may cause damage via repeated overdistension
by itself [29]. It may also be speculated that the lungs
were not recruited frequently enough to prevent atelectasis
in our model. Indeed, HVT mice demonstrated higher
PaO2 levels than LVT mice. Some pulmonary inﬂammation
seen in LVT mice may have been caused by atelecttrauma.
Alternatively, even MV using a VT of 7.5mL/kg could still
cause overdistension of alveoli. Second, the VT used in HVT
mice is quite large. Although there is still underuse of lung-
protective ventilation with the use of lower VT [30, 31],
VT has declined gradually over the past 10 years [32, 33].
Another limitation is that lung injury induced by MV in
our model was generally small. It remains to be determined
(a) whether relative TF deﬁciency is more protective, in
respect to lung injury with more injurious forms of MV, and
(b) whether relative TF deﬁciency protects against VILI in
modelsinwhichanimalswereﬁrstprimedwithinjuredlungs
(e.g., after a ﬁrst hit with lipopolysaccharide or pneumonia).
5. Conclusions
In conclusion, TF deﬁciency is associated with a decreased
pulmonary coagulation independent of the ventilation strat-
egy in a murine model of MV. However, relative TF
deﬁciency does not reduce VILI and even results in higher
pulmonary levels of inﬂammatory mediators.
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